Millennium Management’s RxSight RXST Stock Holding History

Millennium Management’s Portfolio RXST Stock Details RXST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-35,000	Closed	-$1.2M	–	6334
2024 Q4	$1.2M	Buy	+35,000	New	+$1.58M	﹤0.01%	4046
2024 Q1	–	Sell	-75,000	Closed	-$3.02M	–	6578
2023 Q4	$3.02M	Buy	+75,000	New	+$2.2M	﹤0.01%	3238

Other funds holding RXST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NSGL

No Street GP LP San Francisco, California $1.66B AUM 39.91% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Millennium Management's RXST Position: Q2 2026 in Review

Millennium Management increased its RxSight (RXST) stake by 47% in Q2 2026, buying an estimated $5.86M and bringing the position to 3,030,287 shares worth $14.6M. The position accounts for 0.01% of the portfolio, ranked #1921.

Millennium Management first reported a position in RXST in Q3 2021 and has held it in 20 quarters since. The position peaked at $35.5M in Q2 2023. 151 funds tracked by Wall St. Rank hold RXST as of Q2 2026.

Millennium Management held 3,030,287 shares of RxSight worth $14.6M as of Q2 2026.
Millennium Management bought 970,828 RxSight shares in Q2 2026, an estimated $5.86M.
RxSight made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1921 holding.
Millennium Management first reported a position in RxSight in Q3 2021 and has held it in 20 quarters since.
Millennium Management's RxSight position peaked at $35.5M in Q2 2023.
151 funds tracked by Wall St. Rank held RxSight as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.